Bucog, Arceli .

HRN: 26-33-77  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2024
CEFTRIAXONE 1G (VIAL)
12/06/2024
12/20/2024
IV
2G
OD X7days
Tc Acute Appendicitis
Waiting Final Action 
12/06/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/06/2024
12/13/2024
IV
500mg
Q8 X7days
Tc Acute Appendicitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: